[Topical issues of adequate control of dyslipidemia in the prevention of acute and recurrent cerebral circulatory disorders of ischemic type].

Ischemic stroke (IS) is one of the main causes of death and permanent disability. Reducing the burden of stroke is possible if effective preventive measures are provided. The possibilities of correcting lipid metabolism as an important measure aimed at preventing IS are analyzed.

[1]  М. М. Алиева,et al.  Повторный ишемический инсульт при фибрилляции предсердий: частота, гетерогенность, профилактика , 2020 .

[2]  G. Hindricks,et al.  2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[3]  Lawrence A Leiter,et al.  Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract , 2018, European heart journal.

[4]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[5]  M. Walters,et al.  Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses , 2016, European stroke journal.

[6]  B. Huisa,et al.  Atorvastatin in stroke: a review of SPARCL and subgroup analysis , 2010, Vascular health and risk management.

[7]  V. A. Parfenov.  Факторы риска повторного ишемического инсульта и его профилактика , 2010 .

[8]  H. Arif,et al.  Drug compliance after stroke and myocardial infarction: a comparative study. , 2007, Neurology India.